Seed round totalling €7 million. Round reportedly led by unnamed investor(s) with participation from OVNI Capital and several business angels (including founders of Phagos, Genomines and Mistral AI). Funding will support scale-up of astaxanthin production and further development/deployment of the baCtaForge strain engineering platform.
About BaCta
Industrial biotechnology startup developing an AI-driven strain-engineering platform (baCtaForge) to produce sustainable, bio-based ingredients. First commercial product target is a proprietary yeast-derived astaxanthin as a natural, cost-competitive replacement for petrochemical or microalgae sources.
Paris, France
Read Company ProfileFrequently Asked Questions
What type of funding round did BaCta raise?
BaCta raised a seed round.
How much did BaCta raise in its seed?
BaCta raised $7,000,000 EUR in its seed.
Who invested in BaCta's seed?
The investors in BaCta's seed are: OVNI Capital, Several business angels (including founders of Phagos, Genomines and Mistral AI).
What type of investment was BaCta's seed?
BaCta's seed was a equity investment.
How will BaCta use the funds from its seed?
BaCta plans to use the funds for: industrial scale-up and validate production at pilot and commercial stages, leverage strategic partnership to access production capacity, initiate commercialisation, expand baCtaForge platform capabilities to additional high-value ingredients.